January 29, 2016 – 11:42 pm
Jeffrey Shuren, M.D., J.D., the Director of the Center for Device and Radiological Health at the Food and Drug Administration, replied to an open letter from the Leiomyoma Morcellation Review Group. You can read the original open letter here, and view Dr. Shuren’s reply in the images below. The Leiomyoma Morcellation Review Group sent the […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged abdominal myomectomy, FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopic myomectomy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, ovarian cancer, power morcellation, power morcellator
|
December 8, 2015 – 5:00 pm
In November, 2014 the FDA ruled that power morcellation was contra-indicated in “the majority of women” having surgery for uterine fibroids due to the potential risk of spreading occult uterine sarcoma. Although problems with this ruling were immediately apparent, the passage of time has allowed for more clarity on the related medical issues. Prevalence of […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged abdominal myomectomy, FDA, fibroid surgery, fibroids, Food and Drug Administration, laparoscopic myomectomy, leiomyosarcoma, LMS, Morcellation, morcellation and cancer, morcellation risks, morcellator, no hysterectomy, ovarian cancer, power morcellation, power morcellator
|
There is a lot of confusing information circulating about morcellation and uterine leiomyosarcoma in the media since the FDA hearing on this issue a few weeks ago. I plan to post my analysis of the information, in segments, over the next week or two. This first post provides commentary about the numbers used in research […]
By webmaster
|
Posted in Recent Fibroid Research
|
Also tagged FDA, fibroids, laparoscopic myomectomy, LMS, Morcellation, morcellation risks, myomectomy, power morcellation, risk of LMS, risk of Uterine Leiomyosarcoma, robotic myomectomy, uterine leiomyosarcoma
|
As many of you probably know by now, the FDA recently issued a warning saying that morcellation of fibroids during laparoscopic myomectomy (or during laparoscopic hysterectomy) should be avoided because of the risk of uterine leiomyosarcoma (uterine muscle wall cancer). I disagree with this decision (see reasons below) and ask that women who have benefitted […]
January 20, 2010 – 8:24 pm
Hello! I have a fibroid that is uncomfortable due to bulk and extends length of menstruation (7-9 days at least). I recently saw a fertility specialist who did an exam and recommended a “mini” laparoscopy to remove the fibroid. The doctor said the “mini-lap” would involve a three inch (approx) incision at the bikini line. […]
Disclaimer: The ideas, procedures and suggestions contained on this web site are not intended as a substitute for consulting with your physician. All matters regarding your health require medical supervision.